✦ LIBER ✦

W1875 Erythropoietin Use in Patients On Chronic Hepatitis C Treatment: Incidence of Thromboembolic Events and Hepatocellular Carcinoma

✍ Scribed by Werner, Kristina T.; Rosati, Marianne J.; Vargas, Hugo E.; Byrne, Thomas; Rakela, Jorge L.

Book ID: 122058787
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 43 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)63942-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for hepatocellular carcinom

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C

✍ Akinori Kasahara; Norio Hayashi; Kiyoshi Mochizuki; Masahide Takayanagi; Kentaro 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

To elucidate the risk factors for liver carcinogenesis and to examine the incidence of hepatocellular carcinoma (HCC) after interferon therapy, 1,022 chronic hepatitis C patients treated with interferon were followed by ultrasonography for 13 to 97 months (median 36 months). Sustained response with

Incidence of hepatocellular carcinoma in

Incidence of hepatocellular carcinoma in chronic hepatitis B and C: A prospective study of 251 patients

✍ Susumu Takano; Osamu Yokosuka; Fumio Imazeki; Masami Tagawa; Masao Omata 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 655 KB

The incidence of hepatocellular carcinoma (HCC) was prospectively studied in 251 chronic hepatitis patients, and was compared between the 127 cases of hepatitis B and 124 cases of hepatitis C. All patients were diagnosed by needle biopsy on entering the study, and the cases consisted of chronic pers

Incidence of hepatocellular carcinoma in

Incidence of hepatocellular carcinoma in chronic Hepatitis B and C: A prospective study of 251 patients

✍ TAKANO, S 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 675 KB

Lower incidence of hepatic failure than

Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic Hepatitis C

✍ Fumio Imazeki; Osamu Yokosuka; Kenichi Fukai; Shigenobu Kawai; Tatsuo Kanda; Hir 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

The effect of retreatment with interfero

The effect of retreatment with interferon-α on the incidence of hepatocellular carcinoma in patients with chronic hepatitis C

✍ Hidenori Toyoda; Takashi Kumada; Satoshi Nakano; Isao Takeda; Keiichi Sugiyama; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

BACKGROUND. Interferon (IFN) has been reported to have beneficial long term effects that reduce the occurrence of hepatocellular carcinoma (HCC), even in patients who do not have complete responses to IFN. The authors evaluated the effect of retreatment with IFN-␣ on the long term prognoses of those

Varying incidence of cirrhosis and hepat

Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy

✍ Michiko Shindo; Arai Ken; Tadao Okuno 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 3 views

## BACKGROUND. To determine whether interferon (IFN) therapy can reduce incidence of the development of cirrhosis and hepatocellular carcinoma equally in patients with chronic hepatitis C virus (HCV) who responded differently to therapy, a retrospective analysis of 250 patients treated with IFN wa